Branched Dna (bdna) Technology
The branched DNA (bDNA) assay provides a unique and powerful tool for reliable quantification of nucleic acid molecules. Fundamentally different from target amplification methods such as PCR, the bDNA assay directly measures nucleic acid molecules at physiological levels by boosting the reporter signal, rather than replicating target sequences as the means of detection, and hence avoids the errors inherent in the extraction and amplification of target sequences. The bDNA assay employs linear signal amplification using synthetic oligonucleotide probes and bDNA molecules, and can accurately and precisely measure between approximately 500 and 10,000,000 molecules. New advances in bDNA technology include the addition of preamplifier molecules and the incorporation of novel nucleotides, isoC and isoG, into oligonucleotide probe sequences to further enhance signal and reduce noise caused by nonspecific hybridization of bDNA assay components (Kern et al., 1996; Collins et al., 1999). These improvements have extended the quantitative detection limit of the bDNA assay to as low as 50 molecules.
KeywordsSodium Dodecyl Sulfate Human Immunodeficiency Virus Type Target Probe Nucleic Acid Molecule Specific Nucleotide Sequence
Unable to display preview. Download preview PDF.
- Collins ML, Irvine B, Tyner D, Fine E, Zayati C, Chang C A, Horn T, Ahle D, Detmer J, Shen L-P, Kolberg J, Bushnell S, Urdea MS, Ho DD (1997) A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25:2979–2984PubMedCrossRefGoogle Scholar
- Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J (1994) Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337–1341PubMedCrossRefGoogle Scholar
- Flood J, Drew WL, Miner R, Jekic-McMullen D, Shen L-P, Kolberg J, Garvey J, Follansbee S, Poscher M (1997) Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation ofin vivoanti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis 176:348–352PubMedCrossRefGoogle Scholar
- Hendricks DA, Stowe BS, Hoo BJ, Kolberg J, Irvine BD, Neuwald PD, Urdea MS, Perrillo RP (1995) Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Amer J Clin Pathol 104:537–546Google Scholar
- Kolberg JA, Ludtke DN, Shen L-P, Cao W, O’Conner D, Urdea MS, Wuestehube LJ, Lewis M (1998) Branched DNA (bDNA) technology for direct quantification of nucleic acids: research and clinical applications. In Ferré F (Ed) Gene quantification. Birkhäuser, BostonGoogle Scholar